We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Infrared Spectroscopy Combined with AI Automates Detection of Staphylococcus aureus

By LabMedica International staff writers
Posted on 24 Jul 2013
The combination of Fourier transform infrared spectroscopy (FTIR) and artificial neuronal network (ANN) analysis constitutes a system that allows rapid identification and discrimination of the clinically important Staphylococcus aureus capsular serotypes 5, 8, and NT (nontypeable).

The term Fourier transform infrared spectroscopy originates from the fact that a Fourier transform is required to convert the raw data into the actual spectrum. More...
An instrument employing this technique shines a beam containing many frequencies of light at once, and measures how much of that beam is absorbed by the sample. Next, the beam is modified to contain a different combination of frequencies, giving a second data point. This process is repeated many times. Afterwards, a computer takes all these data and works backwards to infer what the absorption was at each wavelength.

Investigators at the University of Veterinary Medicine (Vienna, Austria) combined FTIR spectroscopy with a computerized self-learning system known as an artificial neuronal network (ANN). A comprehensive set of clinical isolates derived from different origins and control strains, representative for each serotype was used to "teach" the system to recognize the spectra emitted by the capsular polysaccharides (CP) present on the surface of the clinically relevant strains of S. aureus.

Studies carried out with the high-throughput ANN-assisted FTIR spectroscopy CP typing system yielded overall accuracy of 96.7% for internal validation and 98.2% for external validation. These results support the use of this system for diagnostic as well as large-scale epidemiologic surveillance of S. aureus capsule expression,

Senior author Dr. Monika Ehling-Schulz, professor of functional microbiology at the University of Veterinary Medicine, said, "In principle, germs have two choices when they infect a host: attack or hide—in technical terms virulence or persistence. If they attack, they risk destroying the host and consequently themselves, whereas if they hide, they may be outcompeted by others. A detailed knowledge of the mechanisms of virulence and persistence and the way bacteria switch between them will help us to develop novel and more effective therapies."

A full description of the ANN-assisted FTIR spectroscopy CP typing system was published in the July 2013 issue of the Journal of Clinical Microbiology.

Related Links:
University of Veterinary Medicine


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.